Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Tisch MS Research Center Stories

2014-04-15 23:02:24

Crowdfunding Gets FDA-Approved Stem Cell Trial Off To Fast Start New York, NY (PRWEB) April 15, 2014 The Tisch MS Research Center of New York (Tisch MSRCNY) today announced that they surpassed their campaign goal on Indiegogo.com to raise funds for their FDA-Approved Phase I Clinical Stem Cell Trial. The funding will be directly applied to the study and stem cell research at Tisch MSRCNY. The target of $300K was met and surpassed within the allotted four weeks of the campaign's launch...

2014-03-17 23:04:21

Crowdfunding Site Targeted to Raise $300K for FDA-Approved Adult Stem Cell Trial New York, NY (PRWEB) March 17, 2014 The Tisch MS Research Center of New York (Tisch MSRCNY) today announced that they have launched a dedicated campaign on Indiegogo to raise funds for their FDA-Approved Phase I Clinical Stem Cell Trial. The non-profit research center aims to raise $300K to be directly applied to the first twenty patients selected to participate in the clinical trial. “We are excited to...

2013-08-14 08:30:14

NEW YORK, Aug. 14, 2013 /PRNewswire/ -- The Tisch MS Research Center of New York announced today that it has received Investigational New Drug (IND) approval from the Food and Drug Administration (FDA) to commence a Phase 1 trial using autologous neural stem cells in the treatment of multiple sclerosis (MS). MS is a chronic human autoimmune disease of the central nervous system that leads to myelin damage and neurodegeneration and affects approximately 2.1 million people worldwide....

2013-04-03 23:03:05

Dr. Saud A. Sadiq to Discuss Cellular Therapy for MS at the Second International Adult Stem Cell Conference: Regenerative Medicine — A Fundamental Shift in Science and Culture. New York, NY (PRWEB) April 03, 2013 The Tisch MS Research Center of New York announced today that Dr. Saud A. Sadiq has accepted an invitation to participate in the Second International Adult Stem Cell Conference: Regenerative Medicine - A Fundamental Shift in Science and Culture to be held within the Vatican,...

2013-02-26 12:27:04

Leading Research Center for Multiple Sclerosis Takes Name of Benefactors NEW YORK, Feb. 26, 2013 /PRNewswire-USNewswire/ -- The Board of Directors of the Multiple Sclerosis Research Center of New York (MSRCNY) today announced the re-naming of the institution as the Tisch MS Research Center of New York. Representing a new model of healthcare, the research center, coupled with its clinical affiliate, the International Multiple Sclerosis Management Practice (IMSMP), is the largest MS...